Novel Antiplatelet and Anticoagulant Agents in the Cardiac Care Unit

Vaani Panse Garg, Jonathan L. Halperin

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


This article reviews the pivotal studies of several novel antiplatelet (prasugrel and ticagrelor) and anticoagulant (dabigatran, rivaroxaban, and apixaban) agents. The clinical use of these drugs in cardiac intensive care is discussed, focusing on the management of acute coronary syndromes, ischemic stroke, atrial fibrillation, and venous thromboembolism.

Original languageEnglish
Pages (from-to)533-544
Number of pages12
JournalCardiology Clinics
Issue number4
StatePublished - Nov 2013


  • Acute coronary syndrome
  • Anticoagulants
  • Antiplatelet drugs
  • Atrial fibrillation
  • Percutaneous coronary intervention
  • Stroke
  • Venous thromboembolism


Dive into the research topics of 'Novel Antiplatelet and Anticoagulant Agents in the Cardiac Care Unit'. Together they form a unique fingerprint.

Cite this